Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute

Conclusion: CAB should be considered as a treatment option for strictly selected patients with mHSPC, even though novel treatments are available.

Source: In Vivo - January 5, 2021 Category: Research Authors: MIYAZAWA, Y., SEKINE, Y., ARAI, S., OKA, D., NAKAYAMA, H., SYUTO, T., NOMURA, M., KOIKE, H., MATSUI, H., SHIBATA, Y., SUZUKI, K. Tags: Clinical Studies Source Type: research